Note: Ingredients listed on restricted chemical lists
EC/CAS
7732-18-5
Name of the chemical
Water, distilled, conductivity or of similar purity H2O
Concentration
N/A
General Information
Revision date
2017-02-01
Product name
Budesonide Inhalation Solution 0.25mg/2mL & 0.5 mg/2mL
Product Synonyms
Budesonide
Chemical name
16, 17-Butylidenebis(oxy)-11,21-dihydroxypregna-1,4-diene-3,20-dione
Icons in SDS
Company Information
company name
Nephron Pharmaceuticals Corporation
Section 2
SECTION 2: Hazards identification
OSHA Carcinogenicity: (NTP) No (IARC) No (OSHA) No Eye: No known significant effects or critical hazards, may cause irritation. Skin: No known significant effects or critical hazards, may cause irritation. Ingestion: No known significant effects or critical hazards. Inhalation: No known significant effects or critical hazards, may cause respiratory irritation.
Potential chronic health
No known significant effects or critical hazards Target Organs: No known significant effects or critical hazards.
Medical Conditions Generally Aggravated by Exposure
long Exposure No known significant effects or critical hazards (See Section 11, “Toxicological Information”)
